Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Le Kang
Observed name:
Kang, Le
Institutions:
Henan University of Chinese Medicine,
Fudan University Shanghai Cancer Center
Observed institutions:
Henan University of Chinese Medicine,
Second Military Medical University,
Fudan University Shanghai Cancer Center,
Changhai Hospital
ORCID:
0009-0008-6741-8408
Observed ORCID:
0009-0008-6741-8408
OpenAlex ID:
A5026726385
Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis
2022
·
Zehua Zhang
, Zhuyun Leng
, et al.
·
Frontiers in Oncology
·
14
PDF
Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
2025
·
Yagang Song
, Shuo Tian
, et al.
·
Journal of Hepatocellular Carcinoma
·
7
PDF
Alcohol accelerates the development of esophageal squamous cell carcinoma through elevated Gram-negative bacteria in peripheral circulation
2025
·
Zehua Zhang
, Le Kang
, et al.
·
Experimental Hematology and Oncology
·
6
Global Trends and Hotspots of Transient Receptor Potential Melastatin 8 Research from 2002 to 2021: A Bibliometric Analysis
2022
·
Zehua Zhang
, Le Kang
, et al.
·
Journal of Pain Research
·
2
PDF
Extracellular vesicles and acetylation: reciprocal regulation in disease progression
2026
·
Yang Liu
, Sinan Wu
, et al.
·
Frontiers in Immunology
PDF
Investigating the shared genetic architecture between inflammatory bowel disease and pancreatitis: a genome-wide cross-trait analysis
2026
·
Hang-Ming Qi
, Ting-Ting Liu
, et al.
·
Molecular Genetics and Genomics
Abstract P2-06-01: CBP/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in TNBC
2025
·
Xueying Yuan
, Xiaoxin Hao
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
12
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type